Accelerate Diagnostics Inc (AXDX)
0.90
0.00 (0.00%)
USD |
NASDAQ |
May 08, 12:23
Accelerate Diagnostics EPS Diluted (Quarterly): -0.81 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.81 |
September 30, 2023 | 0.06 |
June 30, 2023 | -2.97 |
March 31, 2023 | -1.70 |
December 31, 2022 | -1.40 |
September 30, 2022 | -1.83 |
June 30, 2022 | -2.43 |
March 31, 2022 | -2.00 |
December 31, 2021 | -3.49 |
September 30, 2021 | -1.50 |
June 30, 2021 | -3.60 |
March 31, 2021 | -4.10 |
December 31, 2020 | -3.30 |
September 30, 2020 | -3.30 |
June 30, 2020 | -3.50 |
March 31, 2020 | -3.90 |
December 31, 2019 | -3.90 |
September 30, 2019 | -3.70 |
June 30, 2019 | -3.80 |
March 31, 2019 | -4.00 |
December 31, 2018 | -4.10 |
September 30, 2018 | -4.10 |
June 30, 2018 | -4.30 |
March 31, 2018 | -3.70 |
December 31, 2017 | -2.90 |
Date | Value |
---|---|
September 30, 2017 | -3.10 |
June 30, 2017 | -3.10 |
March 31, 2017 | -2.70 |
December 31, 2016 | -3.10 |
September 30, 2016 | -3.40 |
June 30, 2016 | -3.50 |
March 31, 2016 | -2.90 |
December 31, 2015 | -2.90 |
September 30, 2015 | -2.50 |
June 30, 2015 | -2.70 |
March 31, 2015 | -2.00 |
December 31, 2014 | -2.00 |
September 30, 2014 | -2.00 |
June 30, 2014 | -1.90 |
March 31, 2014 | -1.20 |
December 31, 2013 | -1.30 |
September 30, 2013 | -1.00 |
June 30, 2013 | -1.00 |
March 31, 2013 | -0.90 |
October 31, 2012 | -0.70 |
July 31, 2012 | -3.30 |
April 30, 2012 | -0.30 |
January 31, 2012 | -0.30 |
October 31, 2011 | -0.40 |
July 31, 2011 | -0.30 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-4.10
Minimum
Mar 2021
0.06
Maximum
Sep 2023
-2.693
Average
-3.30
Median
Sep 2020
EPS Diluted (Quarterly) Benchmarks
Achieve Life Sciences Inc | -0.24 |
ENDRA Life Sciences Inc | -0.05 |
Tivic Health Systems Inc | -1.530 |
Spectral AI Inc | -0.77 |
Perspective Therapeutics Inc | -0.09 |
EPS Diluted (Quarterly) Related Metrics
Net Income (Quarterly) | -13.00M |
Revenue (Quarterly) | 3.027M |
Total Expenses (Quarterly) | 13.76M |
Enterprise Value | 43.11M |
Gross Profit Margin (Quarterly) | 20.91% |
Profit Margin (Quarterly) | -429.4% |
Earnings Yield | -602.2% |
Normalized Earnings Yield | -497.91 |